SMTL ID : 3wv1.1 (2 other biounits)

Crystal structure of the catalytic domain of MMP-13 complexed with 4-(2-((6-fluoro-2-((3-methoxybenzyl)carbamoyl)-4-oxo-3,4-dihydroquinazolin-5-yl)oxy)ethyl)benzoic acid

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.98 Å
Oligo State
monomer
Ligands
2 x ZN: ZINC ION(Non-covalent)
2 x CA: CALCIUM ION(Non-covalent)
1 x NA: SODIUM ION(Non-functional Binders)
1 x FMT: FORMIC ACID(Non-functional Binders)
1 x WHH: 4-[2-({6-FLUORO-2-[(3-METHOXYBENZYL)CARBAMOYL]-4-OXO-3,4-DIHYDROQUINAZOLIN-5-YL}OXY)ETHYL]BENZOIC ACID(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Nara, H. et al., Discovery of novel, highly potent, and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without a zinc binding group using a structure-based design approach. J.Med.Chem. (2014)
Release Date
2015-05-20
Peptides
Collagenase 3: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Collagenase 3

Related Entries With Identical Sequence

1eub.1 | 1xuc.1 | 1xuc.2 | 1xud.1 | 1xud.2 | 1xur.1 | 1xur.2 | 2yig.1 | 3elm.1 | 3elm.2 | 3i7g.1 | 3i7g.2 | 3i7i.1 | 3i7i.2 | 3wv1.2 | 3wv1.3 | 3wv2.1 | 3wv2.2 | 3wv2.3 | 3wv3.1 | 3wv3.2 | 3wv3.3 | 3zxh.1 | 3zxh.2 | 4l19.1 | 4l19.2 | 4l19.3 | 5bot.1 | 5boy.1 | 5bpa.1  more...